Alterity Therapeutics Lim...

NASDAQ: ATHE · Real-Time Price · USD
5.16
-0.07 (-1.34%)
At close: Aug 15, 2025, 3:09 PM

Alterity Therapeutics Income Statement

Financials in AUD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Revenue
4.02M 3.92M 5.12M 4.34M
Cost of Revenue
214.3K 285.07K 364.67K 360.03K
Gross Profit
3.8M 3.63M 4.76M 3.98M
Operating Income
-19.6M -14.64M -15.5M -15.18M
Interest Income
268.42K 16.44K 2.5K 20.68K
Pretax Income
-19.08M -13.7M -12.78M -15.31M
Net Income
-19.12M -13.81M -12.85M -15.31M
Selling & General & Admin
4.76M 5.04M 5.51M 6.87M
Research & Development
18.64M 13.2M 14.75M 12.28M
Other Expenses
n/a -282.96K -364.67K n/a
Operating Expenses
23.41M 17.35M 17.54M 19.31M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
-9.67K 51.48K 79.33K 21.81K
Cost & Expenses
23.62M 17.63M 17.9M 19.67M
Income Tax Expense
46.09K 104.46K 70.01K n/a
Shares Outstanding (Basic)
6.08M 4.05M 4.01M 2.83M
Shares Outstanding (Diluted)
6.08M 4.05M 4.01M 2.83M
EPS (Basic)
-3.12 -3.42 -3.18 -5.4
EPS (Diluted)
-3.12 -3.42 -3.18 -5.4
EBITDA
-19.57M -17.51M -17.39M -19.36M
EBIT
-19.61M -14.64M -17.45M -15.18M
Depreciation & Amortization
147.53K 102.26K 54.21K 75.37K